序号 |
标题 |
次数 |
作者 |
发布时间 |
72451 |
CAS: 2746391-62-6 MAL-di-EG-Val-Cit-PAB-MMAE |
105 |
zyl |
2024-12-20 |
72452 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate,ADC定制 |
76 |
kx |
2024-12-20 |
72453 |
CAS: 2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH |
108 |
WYQ |
2024-12-20 |
72454 |
Cbz-NH-PEG8-CH2COOH |
153 |
h |
2024-12-20 |
72455 |
CAS: 2055024-60-5,NH2-PEG6-Val-Cit-PAB-OH |
76 |
WYQ |
2024-12-20 |
72456 |
苄基-PEG4-乙酸叔丁酯,cas:1443467-88-6,Benzyl-PEG4-CH2CO2tBu |
71 |
wyh |
2024-12-20 |
72457 |
Boc-NH-PEG6-CH2COOH |
93 |
h |
2024-12-20 |
72458 |
NEs介导的紫杉醇脂质体药物递送系统(NE-LP-PTX),定制服务 |
120 |
axc |
2024-12-20 |
72459 |
perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,抗体药物偶联物(ADC) |
71 |
kx |
2024-12-20 |
72460 |
CAS: 2055024-61-6,NH2-PEG4-Val-Cit-PAB-OH |
72 |
WYQ |
2024-12-20 |
72461 |
Azido-PEG7-CH2COOH |
76 |
h |
2024-12-20 |
72462 |
mb-vc-MGBA-ADC连接子 |
81 |
zyl |
2024-12-20 |
72463 |
Azido-PEG2-CH2COOH |
83 |
h |
2024-12-20 |
72464 |
cas:1263044-88-7,2,5-dioxopyrrolidin-1-yl 1-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)-1-oxo-5,8,11,14-tetraoxa-2-azaheptadecan-17-oate |
55 |
kx |
2024-12-20 |
72465 |
Br-PEG6-CH2COOtBu |
69 |
h |
2024-12-20 |
72466 |
白蛋白结合肽修饰的地塞米松脂质体,ABD-Lip/Dex,定制服务 |
77 |
axc |
2024-12-20 |
72467 |
Maleimido-mono-amide-DOTA cas:1006711-90-5 |
69 |
zyl |
2024-12-20 |
72468 |
2,5-dioxopyrrolidin-1-yl 2-(2-(2-(2-(2,5-dioxo-2H-pyrrol-1(5H)-yl)ethoxy)ethoxy)ethoxy)acetate,ADC定制 |
79 |
kx |
2024-12-20 |
72469 |
Tos-PEG3-CH2COOtBu |
84 |
h |
2024-12-20 |
72470 |
溶菌酶修饰的百里香精油脂质体,定制服务 |
136 |
axc |
2024-12-20 |
72471 |
HO-PEG7-CH2COOH |
120 |
h |
2024-12-20 |
72472 |
Mc-vc-PABC-SP 141 -ADC连接子 |
104 |
zyl |
2024-12-20 |
72473 |
CAS: 2055024-53-6,Boc-PEG6-Val-Cit-PAB-OH |
122 |
WYQ |
2024-12-20 |
72474 |
cas:1252257-56-9,2,5-dioxopyrrolidin-1-yl 3-oxo-1-(pyridin-2-yldisulfanyl)-7,10,13,16,19,22,25,28-octaoxa-4-azahentriacontan-31-oate |
71 |
kx |
2024-12-20 |
72475 |
Amino-PEG12-CH2COOH |
62 |
h |
2024-12-20 |
72476 |
CAS: 2055024-54-7,Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
66 |
WYQ |
2024-12-20 |
72477 |
HO-PEG12-CH2COOH |
73 |
h |
2024-12-20 |
72478 |
cas:663599-07-3,1-(4-((5-(dimethylcarbamoyl)pyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
71 |
kx |
2024-12-20 |
72479 |
E-选择素结合肽修饰并加载四嗪的膜融合脂质体,EBP-Tz-FLs,定制服务 |
99 |
axc |
2024-12-20 |
72480 |
Amino-PEG3-CH2COOH |
74 |
h |
2024-12-20 |
72481 |
CAS: 2055024-55-8,Boc-PEG2-Val-Cit-PAB-OH |
123 |
WYQ |
2024-12-20 |
72482 |
Tos-PEG4-CH2COOH |
88 |
h |
2024-12-20 |
72483 |
cas:663598-85-4,N-succinimidyl 4-(5-nitro-pyridin-2-yldithio)-pentanoate, ADC试剂 |
69 |
kx |
2024-12-20 |
72484 |
负载姜黄素的胆碱修饰的脂质体,NP1/Cur,定制服务 |
85 |
axc |
2024-12-20 |
72485 |
Boc-NH-PEG4-CH2COOH |
64 |
h |
2024-12-20 |
72486 |
CAS: 1951424-92-2,Fmoc-Ala-Ala-Asn(Trt)-OH |
84 |
WYQ |
2024-12-20 |
72487 |
CAS:1618096-56-2 Mc-Dexamethasone 抗体-药物偶联物(ADC) |
107 |
zyl |
2024-12-20 |
72488 |
CAS: 1639939-40-4,MC-Val-Ala-PAB-PNP |
126 |
WYQ |
2024-12-20 |
72489 |
Fmoc-NH-PEG4-CH2COOH |
55 |
h |
2024-12-20 |
72490 |
perfluorophenyl 3-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)propanoate,ADC定制 |
68 |
kx |
2024-12-20 |
72491 |
CAS: 1870916-87-2,MC-Val-Ala-PAB,6-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-N-((S)-1-(((S)-1-((4-(羟甲基)苯基)氨基)-1-氧代丙烷-2-基)氨基)-3-甲基-1-氧代丁-2-基)己酰胺 |
67 |
WYQ |
2024-12-20 |
72492 |
Amino-PEG4-CH2COOH |
96 |
h |
2024-12-20 |
72493 |
CAS号1473403-87-0 MC-SN38 抗体-药物偶联物(ADC) |
115 |
zyl |
2024-12-20 |
72494 |
Alkyne-Val-Cit-PAB-PNP(CAS号:2748039-77-0) |
67 |
WYQ |
2024-12-20 |
72495 |
Fmoc-NH-PEG4-CH2CH2COOH |
108 |
h |
2024-12-20 |